Liver targeting molecules

A liver-targeted, molecular technology applied in the field of single variable domains of immunoglobulins (antibodies), which can solve problems such as virus resistance and side effects that hinder the development and widespread use of compounds

Inactive Publication Date: 2012-11-21
GLAXO GRP LTD
View PDF13 Cites 12 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0008] However, issues regarding viral resistance and side effects have hampered the development and general use of these compounds in many cases

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Liver targeting molecules
  • Liver targeting molecules
  • Liver targeting molecules

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0171] Example 1: Cloning and expression of human and mouse asialoglycoprotein H1 receptor subunits

[0172] Full-length human and mouse asialoglycoprotein H1 receptor subunit (ASGPR H1) cDNAs were custom-synthesized by DNA2.0 (Mealo Park CA, USA). Using primers DLT007 and DLT008 (human) or DLT009 and DLT010 (mouse), amplify by PCR coding with N-terminal (His) 6 Tag the DNA for the extracellular domain (Q62-L291 for human, and S60-N284 for mouse). The sequences are shown in Table 1 below.

[0173] Table 1:

[0174]

[0175] The PCR fragment was inserted into the containment vector pCR-Zero Blunt (Invitrogen) by topoisomerase cloning and sequenced to obtain error-free clones using M13 forward and M13 reverse primers. Obtained by gel purification after BamHI / HindIII digestion of pCR-Zero Blunt containing the insert (His) 6 - ASGPR H1 encoding DNA and ligation of the insert into the corresponding sites in pDOM50, which is a mammalian expression vector which is a derivative...

Embodiment 2

[0192] Example 2 - Method for selecting dAbs

[0193] Domantis' 4G and 6G naive phage libraries displaying for 4G an antibody single variable domain expressed from the GAS1 leader (see WO2005 / 093074) and for 6G additionally having heat / Cold preselection (see WO04 / 101790); pool 1 contains libraries 4VH11-13 and 6VH2, pool 2 contains libraries 4VH14-16 and 6VH3, pool 3 contains libraries 4VH17-19 and 6VH4, and pool 4 contains libraries 4K and 6K. Library aliquots were of sufficient size to allow 10-fold overrepresentation of each library. Option to use passive coated and biotinylated human and mouse (His) 6 - ASGPR H1 antigen execution. Selection using passively coated antigens was performed as follows. on immunotubes (Nunc) supplemented with 5 mM Ca2 +（ TBS / Ca 2+ ) in TBS, will work with 2% Marvel's TBS / Ca 2+（ MTBS / Ca 2+ ) solution closed. Will work with TBS / Ca 2+ Prior to washing, store aliquots of the library in MTBS / Ca 2+ incubate. Bound phage were then eluted wi...

Embodiment 3

[0196] Example 3 - Screening for selection output of liver cell-specific dAbs

[0197] After 3 rounds of selection, the dAb genes from each library pool were subcloned from the pDOM4 phage vector into the pDOM10 soluble expression vector. pDOM4 is a derivative of the fd phage vector in which the gene III signal peptide sequence is replaced with the yeast glycolipid-anchored surface protein (GAS) signal peptide. It also contains a c-Myc tag between the leader sequence and gene III. In each case, after selection, phage DNA libraries from appropriate selection cycles were prepared using the QIAfilter midiprep kit (Qiagen), the DNA was digested with restriction enzymes Sal1 and Not1, and the enriched dAb genes were ligated into pDOM10. within the corresponding location.

[0198]The pDOM10 vector is a pUC119-based vector. Protein expression is driven by the LacZ promoter. The GAS1 leader sequence (see WO 2005 / 093074) ensures secretion of the isolated soluble dAbs into the perip...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
affinityaaaaaaaaaa
Login to view more

Abstract

The present invention relates to molecules that can be targeted to the liver. These liver targeting molecules (e.g. fusions and conjugates) comprise proteins, antibodies or antibody fragments such as immunoglobulin (antibody) single variable domains (dAbs) and also one or more additional molecules which it is desired to deliver to the liver such as interferons. The invention further relates to uses, formulations, compositions and devices comprising such liver targeting molecules. The invention also relates to immunoglobulin (antibody) single variable domains which bind to hepatocytes.

Description

[0001] The present invention relates to molecules that can be targeted to the liver. These liver-targeting molecules (such as fusions and conjugates) comprise proteins, antibodies or antibody fragments such as immunoglobulin (antibody) single variable domains (dAbs), and one or more additional Molecules such as interferon. The invention further relates to uses, formulations, compositions and devices comprising such liver targeting molecules. The invention also relates to immunoglobulin (antibody) single variable domains that bind hepatocytes. Background of the invention [0002] Liver disease is a term describing a number of disease states including (but not limited to): [0003] 1) hepatitis, inflammation of the liver caused in many cases by viral infection; [0004] 2) cirrhosis, which involves fibrous deposits following tissue remodeling in the liver typically following viral infection or exposure to hepatotoxic agents such as alcohol; and [0005] 3) Liver cancer, incl...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K39/395C07K16/28A61P35/00A61P31/14C12N5/10C12N15/63C12N15/13C07K19/00A61K47/48A61P1/16
CPCA61K39/395C07K16/2851A61K39/39541C07K2317/569C07K16/28A61P1/16A61P31/14A61P31/20A61P35/00
Inventor G.邓莱维S.霍尔梅斯洪志A.塞普A.沃克
Owner GLAXO GRP LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap